Company profile: Thor Photomedicine
1.1 - Company Overview
Company description
- Provider of photobiomodulation (PBM) therapy using laser or LED light to improve tissue repair, reduce inflammation and relieve pain. Offers FDA- and CE-cleared THOR LX2.3 for oral mucositis, tendinopathies, and joint, neck and back pain, NovoTHOR whole-body PBM, and training for clinicians. Serves pioneering clinics and hospitals in 70 countries; the only LLLT company.
Products and services
- THOR LX2.3 Photobiomodulation System: FDA/CE-cleared PBM system engineered to treat oral mucositis, tendinopathies, and joint, neck, and back pain for various therapeutic applications
- NovoTHOR: Whole-body PBM system that uses light therapy to promote healing and pain relief across the entire body
- Photobiomodulation (PBM) Therapy: LED/laser-based therapy that improves tissue repair, reduces inflammation, and alleviates pain in musculoskeletal disorders and other conditions
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Thor Photomedicine
Concentric Analgesics
HQ: United States
Website
- Description: Provider of non-opioid therapeutics for acute and chronic pain, including Vocacapsaicin (CA-008), a single-administration prodrug for postsurgical pain; CA-051 for epidural treatment of refractory pain associated with cancer or following amputation; and a novel injection for chronic osteoarthritis pain.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Concentric Analgesics company profile →
Heron Therapeutics
HQ: United States
Website
- Description: Provider of polymer-based pharmaceuticals for acute and oncology care, offering therapies to reduce postsurgical pain and prevent nausea and vomiting from chemotherapy and surgery. Products include SUSTOL (5-HT3 antagonist), CINVANTI (IV NK1 antagonist), ZYNRELEF (bupivacaine + meloxicam), and APONVIE (IV NK1 antagonist), plus Acute Care Solutions and Oncology Care Solutions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Heron Therapeutics company profile →
NanoVibronix
HQ: United States
Website
- Description: Provider of portable therapeutic ultrasound medical devices, including PainShield, a wearable device delivering localized energy to relieve pain and promote soft tissue healing; UroShield, a urology device that creates an acoustic shield on urinary catheters to prevent bacterial biofilm, reduce infections, and alleviate catheter-related pain and discomfort; and WoundShield, a patch-based device that promotes wound healing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full NanoVibronix company profile →
Theralase
HQ: Canada
Website
- Description: Provider of biopharmaceutical therapies including Anti-Cancer Therapy (ACT) using light-activated photo dynamic compounds to destroy cancer cells; Cool Laser Therapy (CLT) for knee pain relief by reducing inflammation and accelerating healing; a Phase II NMIBC clinical study of TLD-1433; and Rutherrin, an intravenous combination of TLD-1433 with transferrin to target and destroy cancer cells.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Theralase company profile →
Arteaus Therapeutics
HQ: United States
Website
- Description: Provider of biotechnology development focused on creating new therapies to treat and prevent migraine; Cambridge, Massachusetts-based.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Arteaus Therapeutics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Thor Photomedicine
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Thor Photomedicine
2.2 - Growth funds investing in similar companies to Thor Photomedicine
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Thor Photomedicine
4.2 - Public trading comparable groups for Thor Photomedicine
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →